Company Filing History:
Years Active: 2011
Title: Yiwen Li: Innovator in Anti-Cancer Antibodies
Introduction: Yiwen Li is a prominent inventor based in Jersey City, NJ (US). She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. Her work focuses on innovative solutions for treating leukemia, showcasing her dedication to advancing medical science.
Latest Patents: Yiwen Li holds a patent for Anti-FLT3 antibodies. This invention provides fully human antibodies that specifically bind to human FLT3 within extracellular domains 4 or 5 with high affinity. The patent further outlines methods of treating leukemia by administering an effective amount of the antibody, either alone or in combination with anti-cancer agents, including methotrexate.
Career Highlights: Throughout her career, Yiwen has demonstrated exceptional expertise in antibody development. Her work at Imclone LLC has positioned her as a key player in the biotechnology industry. She has successfully navigated the complexities of patent applications, ensuring that her innovations are protected and can benefit patients in need.
Collaborations: Yiwen Li collaborates with talented professionals in her field, including Dan Lu and David Surguladze. These partnerships enhance her research and contribute to the success of her projects.
Conclusion: Yiwen Li's contributions to the field of anti-cancer therapies through her innovative patents exemplify her commitment to improving patient outcomes. Her work continues to inspire advancements in medical research and biotechnology.